Immunis to use MRI-based AI muscle analysis for sarcopenia trial
Immunis has enlisted the services of Springbok Analytics in its Phase I/II clinical trial for a sarcopenia therapy, leveraging the…
Immunis has enlisted the services of Springbok Analytics in its Phase I/II clinical trial for a sarcopenia therapy, leveraging the…